Utility of blood procalcitonin concentration in the management of cancer patients with infections
Research output: Contribution to journal › Review › Research › peer-review
Standard
Utility of blood procalcitonin concentration in the management of cancer patients with infections. / Durnas, Bonita; Watek, Marzena; Wollny, Tomasz; Niemirowicz, Katarzyna; Marzec, Michal; Bucki, Robert; Gozdz, Stanislaw.
In: OncoTargets and Therapy, Vol. 9, 2016, p. 469-475.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Utility of blood procalcitonin concentration in the management of cancer patients with infections
AU - Durnas, Bonita
AU - Watek, Marzena
AU - Wollny, Tomasz
AU - Niemirowicz, Katarzyna
AU - Marzec, Michal
AU - Bucki, Robert
AU - Gozdz, Stanislaw
PY - 2016
Y1 - 2016
N2 - Diagnosis of infections in cancer patients is usually problematic since differentiating between infection and fever of unknown origin is often a considerable clinical challenge. In general, increase concentration of blood procalcitonin (PCT) is associated with severe bacterial infection. PCT with an optimal cutoff level of 0.5 ng/mL seems to be the most helpful biochemical parameter in detecting severe infections, mainly bloodstream infection, in patients with hematological cancers. In all clinical situations, the elevated level of PCT should be carefully analyzed, always with a thorough physical examination and an appropriate microbiological assessment.
AB - Diagnosis of infections in cancer patients is usually problematic since differentiating between infection and fever of unknown origin is often a considerable clinical challenge. In general, increase concentration of blood procalcitonin (PCT) is associated with severe bacterial infection. PCT with an optimal cutoff level of 0.5 ng/mL seems to be the most helpful biochemical parameter in detecting severe infections, mainly bloodstream infection, in patients with hematological cancers. In all clinical situations, the elevated level of PCT should be carefully analyzed, always with a thorough physical examination and an appropriate microbiological assessment.
KW - procalcitonin
KW - cancer
KW - infection
U2 - 10.2147/OTT.S95600
DO - 10.2147/OTT.S95600
M3 - Review
C2 - 26858528
VL - 9
SP - 469
EP - 475
JO - OncoTargets and Therapy
JF - OncoTargets and Therapy
SN - 1178-6930
ER -
ID: 179649529